Category Archive: 3.) Investec

Swiss stock market rally loses momentum

The Swiss Market Index and global stock markets failed to extend last week’s rally after the Federal Reserve and Bank of Japan left rates unchanged and gave mixed messages about the global economic outlook.

Read More »

UBS beats profit estimates as CEO pushes ahead with cost cuts

UBS Group AG beat analysts’ second-quarter profit estimates and said it’s on track to cut costs by 2.1 billion Swiss francs ($2.2 billion) through 2017, with Chief Executive Officer Sergio Ermotti struggling wi...

Read More »

Credit Suisse’s turnaround is working, but vulnerable

Brought to you by Investec Switzerland. Just a month ago, Credit Suisse CEO Tidjane Thiam and Deutsche Bank CEO John Cryan risked, as one hedge fund manager put it, becoming the dead men walking of European banking as they struggled to shore up their...

Read More »

Swiss markets fluctuate on earnings data

The Swiss Market Index is set to finish the week slightly higher as investors digest second quarter earnings reports and central bank policy announcements.

Read More »

Roche CEO worried about U.K. drug research following Brexit

The U.K.’s decision to leave the European Union poses a threat to research and development in the pharmaceutical industry, Roche Holding AG Chief Executive Officer Severin Schwan said. A departure would mean the country would have to set up its own system for approving drugs for sale, a job now done for bloc members by the European Medicines Agency.

Read More »

Givaudan profit beats estimates on U.S. fragrance demand

Givaudan SA, the world’s largest flavors and fragrance company, reported first-half profit that beat analyst estimates on increased demand for perfumes. Earnings before interest, taxes, depreciation and amortization rose 13 percent to 638 million francs ($649 million), the Vernier, Switzerland-based company said in a statement on Monday. Analysts had predicted 576 million francs. Sales gained 6.2 percent on a like-for-like basis to 2.33 billion...

Read More »

Novartis says profit may drop

Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec. Core operating income will either be about the same as 2015 or decline by a percentage in the low single digits at constant exchange rates, Novartis said Tuesday in a statement. Sales will show little change.

Read More »

Swatch profit plunges as demand falls across europe, asia

Swatch Group AG said first-half profit fell by more than half — the most in at least 15 years — as demand for its watches in Hong Kong, France and Switzerland collapsed.

Read More »

Swiss stocks higher on stimulus bet

The Swiss Market Index (SMI) is set to finish this week higher tracking equity market gains around the world as investors begin to anticipate a new wave of economic stimulus from central banks.

Read More »

Swiss government rejects union demands for pension increases

Various Swiss unions along with the socialist and green parties have launched an initiative to increase pensions. Their plan, which demands a 10% increase in pension payments, will be put before Swiss voters in a referendum on 25 September 2016.

Read More »

QE and stress tests could cause a state of emergency for some insurers

European insurers, whose profits are being eroded by Mario Draghi’s quantitative-easing program, face a stress-test headache that risks requiring them to set aside more capital, further hurting their ability to make money. The timing of the regulator’s “stress test couldn’t be worse as the results will be rather negative,” said Lutz Roehmeyer, who helps oversee about $12 billion as director of fund management at Landesbank Berlin Investment.

Read More »

Post-Brexit relief rally fading – Swiss quality stocks as safe haven

The SMI is set to post moderate losses this week as the post-Brexit relief rally faded and commodities slipped. Swiss stocks outperformed key European markets as investor’s fled to quality stocks such as Nestlé, Novartis and Roche.

Read More »

Some question price of Swiss stocks as safe haven status awakened

Swiss stocks, dislodged in 2015 as a haven from European volatility, have seen the status restored following Brexit — so much that some investors are balking at valuations. After trailing shares from Germany to France and Italy for most the past year, the Swiss Market Index is finding a new appeal in the fallout of the U.K. vote to leave the European Union.

Read More »

SMI up on Brexit bargain hunting

Investec's weekly view on Stock Markets and the SMI. Global equity markets are set to post gains this week as investors digest the impact of the UK’s historic vote to leave the European Union. Swiss stocks outperformed global markets as defensive heavyweights Nestle outperformed.

Read More »

Brexit shakes global markets and the SMI

The Swiss Market Index (SMI) is set to post a modest gain this week despite confirmation that the UK has decided to leave the European Union. The SMI opened almost 7% lower following the announcement before recovering.

Read More »

Swiss tax redistribution in 2017 – winners and losers

Switzerland has a system known as la péréquation financière nationale in French, or Finanzausgleich in German, which requires “rich” cantons to give money to “poor” cantons. Yesterday, the Swiss federal government published the numbers for 2017.

Read More »